These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31522738)

  • 21. Pharmacologically induced ultrastructural and immunohistochemical changes in the prostate of the castrated dog.
    Aumüller G; Habenicht UF; el Etreby MF
    Prostate; 1987; 11(3):211-8. PubMed ID: 2446297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aromatase inhibitors: basic and clinical studies.
    Brodie AM; Coombes RC; Dowsett M
    J Steroid Biochem; 1987; 27(4-6):899-903. PubMed ID: 3320568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of aromatase inhibitor, TZA-2209, on the prostate of androstenedione-treated castrated dogs: changes in prostate volume and histopathological findings.
    Suzuki K; Ito K; Tamura Y; Suzuki T; Honma S; Yamanaka H
    Prostate; 1996 May; 28(5):328-37. PubMed ID: 8610061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergic inhibitory effects of the aromatase inhibitor 1-methyl-androsta-1, 4-diene-3, 17-dione and the antiandrogen cyproterone acetate on androstenedione-induced hyperplastic effects in the prostates of castrated dogs.
    Habenicht UF; el Etreby MF
    Prostate; 1987; 11(2):133-43. PubMed ID: 2444953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of in vivo administration of 10-propargylestr-4-ene-3,17-dione on rat ovarian aromatase and estrogen levels.
    Brandt ME; Covey DF; Zimniski SJ
    J Enzyme Inhib; 1990; 4(2):143-52. PubMed ID: 2098521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of 4-hydroxyandrostenedione and hyperstimulation with pregnant mare serum gonadotrophin on early embryonic development in rats.
    Tong TY; Goh VH
    Can J Physiol Pharmacol; 2001 Sep; 79(9):744-53. PubMed ID: 11599774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atamestane: an aromatase inhibitor for the treatment of benign prostatic hyperplasia. A short review.
    el Etreby MF
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):565-72. PubMed ID: 7682838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neonatal estrogen exposure induces lobe-specific alterations in adult rat prostate androgen receptor expression.
    Prins GS
    Endocrinology; 1992 Jun; 130(6):3703-14. PubMed ID: 1597166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal estrogen exposure induces lobe-specific alterations in adult rat prostate androgen receptor expression.
    Prins GS
    Endocrinology; 1992 Apr; 130(4):2401-12. PubMed ID: 1547747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism of androgens in human benign prostatic hyperplasia: aromatase and its inhibition.
    Bartsch W; Klein H; Stürenburg HJ; Voigt KD
    J Steroid Biochem; 1987; 27(1-3):557-64. PubMed ID: 2447391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a new steroidal aromatase inhibitor, TZA-2237, and/or chlormadinone acetate on hormone-induced and spontaneous canine benign prostatic hyperplasia.
    Ito K; Fukabori Y; Shibata Y; Suzuki K; Mieda M; Gotanda K; Honma S; Yamanaka H
    Eur J Endocrinol; 2000 Oct; 143(4):543-54. PubMed ID: 11022202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The aromatase inhibitor, 4-hydroxyandrostenedione, restores immune responses following trauma-hemorrhage in males and decreases mortality from subsequent sepsis.
    Schneider CP; Nickel EA; Samy TS; Schwacha MG; Cioffi WG; Bland KI; Chaudry IH
    Shock; 2000 Sep; 14(3):347-53. PubMed ID: 11028555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of estrogen-related hyperplastic changes in the prostate of the cynomolgus monkey (Macaca fascicularis) by androstenedione and its antagonization by the aromatase inhibitor 1-methyl-androsta-1,4-diene-3,17-dione.
    Habenicht UF; Schwarz K; Neumann F; el Etreby MF
    Prostate; 1987; 11(4):313-26. PubMed ID: 2446299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular and morphometric analysis of the rat ventral prostate injected with leptin.
    Alves-Pereira JL; Colli S; Marques DS; Sampaio FJ; Ramos CF
    Regul Pept; 2012 Jun; 176(1-3):6-12. PubMed ID: 22387703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastric estrogen directly induces ghrelin expression and production in the rat stomach.
    Sakata I; Tanaka T; Yamazaki M; Tanizaki T; Zheng Z; Sakai T
    J Endocrinol; 2006 Sep; 190(3):749-57. PubMed ID: 17003276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripubertal aromatase inhibition in male rats has adverse long-term effects on bone strength and growth and induces prostatic hyperplasia.
    Bajpai A; Simm PJ; McPherson SJ; Russo VC; Azar WJ; Wark JD; Risbridger GP; Werther GA
    J Endocrinol; 2010 Oct; 207(1):27-34. PubMed ID: 20675302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aromatase and its inhibitors--an overview.
    Brodie A
    J Steroid Biochem Mol Biol; 1991; 40(1-3):255-61. PubMed ID: 1958529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 6beta,19-Bridged androstenedione analogs as aromatase inhibitors.
    Komatsu S; Yaguchi A; Yamashita K; Nagaoka M; Numazawa M
    Steroids; 2009 Nov; 74(12):884-9. PubMed ID: 19524602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective inhibition of androstenedione-induced prostate growth in intact beagle dogs by a combined treatment with the antiandrogen cyproterone acetate and the aromatase inhibitor 1-methyl-androsta-1,4-diene-3,17-dione (1-methyl-ADD).
    Habenicht UF; el Etreby MF
    Prostate; 1989; 14(4):309-22. PubMed ID: 2473459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo studies with aromatase inhibitor 4-hydroxy-androstenedione.
    Brodie AM; Wing LY
    Steroids; 1987; 50(1-3):89-103. PubMed ID: 3504069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.